According to Ameke's announcement, Beijing Norbot Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, has received the “Drug Registration Certificate” for lidocaine cream approved and issued by the State Drug Administration. This drug is a prescription drug with 3 types of chemicals. It is suitable for adult intact skin. It provides local analgesia for superficial skin surgery. The marketing license holder is Norbot. Obtaining a certificate this time enriches the company's product matrix. After the product is launched in the future, it will have a synergy effect with existing products, and there is uncertainty about its future sales situation.

According to Ameke's announcement, Beijing Norbot Biotechnology Co., Ltd., a wholly-owned subsidiary of the company, has received the “Drug Registration Certificate” for lidocaine cream approved and issued by the State Drug Administration. This drug is a prescription drug with 3 types of chemicals. It is suitable for adult intact skin. It provides local analgesia for superficial skin surgery. The marketing license holder is Norbot. Obtaining a certificate this time enriches the company's product matrix. After the product is launched in the future, it will have a synergy effect with existing products, and there is uncertainty about its future sales situation.